Medpace Holdings Inc (NASDAQ: MEDP) started the day on Wednesday, with a price increase of 9.15% at $358.27, before settling in for the price of $328.24 at the close. Taking a more long-term approach, MEDP posted a 52-week range of $268.16-$459.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 22.02% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 35.06%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.76%. This publicly-traded company’s shares outstanding now amounts to $30.68 million, simultaneously with a float of $25.55 million. The organization now has a market capitalization sitting at $11.14 billion. At the time of writing, stock’s 50-day Moving Average stood at $342.20, while the 200-day Moving Average is $376.95.
Medpace Holdings Inc (MEDP) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Medpace Holdings Inc’s current insider ownership accounts for 17.81%, in contrast to 81.78% institutional ownership. According to the most recent insider trade that took place on Aug 22 ’24, this organization’s Director sold 4,353 shares at the rate of 390.73, making the entire transaction reach 1,700,848 in total value, affecting insider ownership by 520. Preceding that transaction, on Aug 23 ’24, Company’s Director sold 3,774 for 390.73, making the whole transaction’s value amount to 1,474,615. This particular insider is now the holder of 520 in total.
Medpace Holdings Inc (MEDP) Earnings and Revenue Records
Medpace Holdings Inc’s EPS increase for this current 12-month fiscal period is 33.76% and is forecasted to reach 12.53 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 15.15% through the next 5 years, which can be compared against the 35.06% growth it accomplished over the previous five years trading on the market.
Medpace Holdings Inc (NASDAQ: MEDP) Trading Performance Indicators
Let’s observe the current performance indicators for Medpace Holdings Inc (MEDP). It’s Quick Ratio in the last reported quarter now stands at 0.99. The Stock has managed to achieve an average true range (ATR) of 12.91. Alongside those numbers, its PE Ratio stands at $31.37, and its Beta score is 1.37. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.38. Similarly, its price to free cash flow for trailing twelve months is now 20.79.
In the same vein, MEDP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 11.42, a figure that is expected to reach 2.94 in the next quarter, and analysts are predicting that it will be 12.53 at the market close of one year from today.
Technical Analysis of Medpace Holdings Inc (MEDP)
If we take a close look at the recent performances of Medpace Holdings Inc (NASDAQ: MEDP), its last 5-days Average volume was 0.37 million that shows progress from its year to date volume of 0.28 million. During the previous 9 days, stock’s Stochastic %D was recorded 64.44% While, its Average True Range was 13.49.
Raw Stochastic average of Medpace Holdings Inc (MEDP) in the period of the previous 100 days is set at 35.66%, which indicates a major fall in contrast to 90.19% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 57.02% that was higher than 51.15% volatility it exhibited in the past 100-days period.
